NYSE:BAX Baxter International (BAX) Stock Price, News & Analysis $24.58 +0.08 (+0.31%) Closing price 03:59 PM EasternExtended Trading$24.54 -0.04 (-0.16%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About Baxter International Stock (NYSE:BAX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Baxter International alerts:Sign Up Key Stats Today's Range$24.31▼$24.7050-Day Range$21.76▼$31.2352-Week Range$21.33▼$40.49Volume2.62 million shsAverage Volume5.32 million shsMarket Capitalization$12.62 billionP/E RatioN/ADividend Yield2.77%Price Target$30.11Consensus RatingHold Company Overview Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois. Read More Baxter International Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks95th Percentile Overall ScoreBAX MarketRank™: Baxter International scored higher than 95% of companies evaluated by MarketBeat, and ranked 58th out of 945 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.1 / 5Analyst RatingHold Consensus RatingBaxter International has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on 3 buy ratings, 6 hold ratings, and 1 sell rating.Amount of Analyst CoverageBaxter International has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Baxter International's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth10.08% Earnings GrowthEarnings for Baxter International are expected to grow by 10.08% in the coming year, from $2.48 to $2.73 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Baxter International is -81.82, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Baxter International is -81.82, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioBaxter International has a PEG Ratio of 0.80. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioBaxter International has a P/B Ratio of 1.73. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Baxter International's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.73% of the float of Baxter International has been sold short.Short Interest Ratio / Days to CoverBaxter International has a short interest ratio ("days to cover") of 3.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Baxter International has recently increased by 4.20%, indicating that investor sentiment is decreasing. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldBaxter International pays a meaningful dividend of 2.77%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthBaxter International does not have a long track record of dividend growth.Dividend SustainabilityBased on earnings estimates, Baxter International will have a dividend payout ratio of 24.91% next year. This indicates that Baxter International will be able to sustain or increase its dividend.Read more about Baxter International's dividend. Sustainability and ESG4.0 / 5Environmental Score-1.95 Percentage of Shares Shorted3.73% of the float of Baxter International has been sold short.Short Interest Ratio / Days to CoverBaxter International has a short interest ratio ("days to cover") of 3.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Baxter International has recently increased by 4.20%, indicating that investor sentiment is decreasing. News and Social Media3.0 / 5News Sentiment0.40 News SentimentBaxter International has a news sentiment score of 0.40. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.98 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 9 news articles for Baxter International this week, compared to 8 articles on an average week.Search Interest10 people have searched for BAX on MarketBeat in the last 30 days. This is an increase of 67% compared to the previous 30 days.MarketBeat Follows5 people have added Baxter International to their MarketBeat watchlist in the last 30 days. This is an increase of 400% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Baxter International insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.20% of the stock of Baxter International is held by insiders.Percentage Held by Institutions90.19% of the stock of Baxter International is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Baxter International's insider trading history. Receive BAX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Baxter International and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BAX Stock News HeadlinesIs Now The Time To Buy Baxter Stock?August 26 at 9:18 AM | forbes.comBaxter International Inc. (NYSE:BAX) Receives Average Recommendation of "Hold" from AnalystsAugust 26 at 2:33 AM | americanbankingnews.comINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.August 27 at 2:00 AM | Traders Agency (Ad)Medical Devices & Supplies - Diversified Stocks Q2 In Review: Baxter (NYSE:BAX) Vs PeersAugust 22, 2025 | finance.yahoo.comBaxter International Inc. stock outperforms competitors despite losses on the dayAugust 22, 2025 | marketwatch.comHow hurricanes, fires, and floods put drugs and medical supplies at riskAugust 21, 2025 | bostonglobe.comBIs There An Opportunity With Baxter International Inc.'s (NYSE:BAX) 33% Undervaluation?August 15, 2025 | finance.yahoo.comHere’s Why You Should Consider Selling Your Baxter (BAX) SharesAugust 13, 2025 | msn.comSee More Headlines BAX Stock Analysis - Frequently Asked Questions How have BAX shares performed this year? Baxter International's stock was trading at $29.16 at the beginning of 2025. Since then, BAX shares have decreased by 15.9% and is now trading at $24.5250. How were Baxter International's earnings last quarter? Baxter International Inc. (NYSE:BAX) posted its quarterly earnings data on Thursday, July, 31st. The medical instruments supplier reported $0.59 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.60 by $0.01. Baxter International's revenue was up 4.3% on a year-over-year basis. Read the conference call transcript. Does Baxter International have any subsidiaries? Baxter International subsidiaries include these companies: Cheetah Medical, ApaTech Limited, Baxter AO, Baxter Belgium SPRL, Baxter (China) Investment Co. Ltd, Baxter Company Ltd, Baxter Corporation (Canada), and more. Who are Baxter International's major shareholders? Baxter International's top institutional shareholders include Dodge & Cox (10.15%), Bank of New York Mellon Corp (2.57%), Geode Capital Management LLC (2.51%) and Ameriprise Financial Inc. (1.49%). Insiders that own company stock include Jeanne K Mason, Albert P L Stroucken and Jacqueline Kunzler. View institutional ownership trends. How do I buy shares of Baxter International? Shares of BAX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Baxter International own? Based on aggregate information from My MarketBeat watchlists, some other companies that Baxter International investors own include Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), Exxon Mobil (XOM), Chevron (CVX), JPMorgan Chase & Co. (JPM) and Intel (INTC). Company Calendar Record date for 7/1 Dividend5/30/2025Ex-Dividend for 7/1 Dividend5/30/2025Dividend Payable7/01/2025Last Earnings7/31/2025Today8/27/2025Record date for 10/1 Dividend8/29/2025Ex-Dividend for 10/1 Dividend8/29/2025Dividend Payable10/01/2025Next Earnings (Estimated)11/14/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry MED PRODUCTS Sub-IndustryHealth Care Equipment Current SymbolNYSE:BAX CIK10456 Webwww.baxter.com Phone(224) 948-2000Fax224-948-1813Employees38,000Year Founded1931Price Target and Rating Average Price Target for Baxter International$30.11 High Price Target$42.00 Low Price Target$24.00 Potential Upside/Downside+22.8%Consensus RatingHold Rating Score (0-4)2.20 Research Coverage10 Analysts Profitability EPS (Trailing Twelve Months)($0.30) Trailing P/E RatioN/A Forward P/E Ratio9.89 P/E Growth0.8Net Income-$649 million Net Margins-1.42% Pretax Margin-2.96% Return on Equity16.96% Return on Assets5.24% Debt Debt-to-Equity Ratio1.30 Current Ratio2.30 Quick Ratio1.49 Sales & Book Value Annual Sales$10.89 billion Price / Sales1.16 Cash Flow$4.74 per share Price / Cash Flow5.17 Book Value$14.20 per share Price / Book1.73Miscellaneous Outstanding Shares513,621,000Free Float512,594,000Market Cap$12.60 billion OptionableOptionable Beta0.59 Social Links 7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (NYSE:BAX) was last updated on 8/27/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Baxter International Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Baxter International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.